MolNFT v1 · #90936 · protein
MAPK13 complex with inhibitor
4EYM · Mitogen-activated protein kinase 13: “MAPK13 complex with inhibitor”. X-ray diffraction, 1 ligand (0RX), 1 pocket (best druggability 0.69). MolNFT v1 #90936 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4EYM
- Type
- protein
- Length
- 340 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mitogen-activated protein kinase 13
- EC
- 2.7.11.24
- UniProt
- O15264
- Ligands
- 0RX
- Pockets
- 1 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 37% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mitogen-activated protein kinase 13 (EC 2.7.11.24) | protein | 340 | 37% helix, 16% strand | O15264 |
Ligands and binding sites
- 0RX · 2-(morpholin-4-yl)-N-[4-(pyridin-4-yloxy)phenyl]pyridine-4-carboxamide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 436 | 0.69 | 0.80 | 46 | 0RX |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O15264
- Elsewhere: RCSB PDB 4EYM · PDBe 4EYM · UniProt O15264
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.